Enable JavaScript to visit this website.
Skip directly to content

Pfizer Canada Update - Supply of Essential Medicines


March 18, 2020 – Pfizer Canada takes seriously the presence of the novel coronavirus (COVID-19) in Canada. In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic.

We are closely monitoring the impact of COVID-19 on our supply chain and as of now, we have not seen any disruption or impact to our business. We are working to ensure continued access of our medicines and vaccines to patients across Canada. We consistently and diligently monitor the supply of our medicines for preparedness and contingency planning to help ensure products are available for our patients.  Furthermore, business continuity plans at our manufacturing sites have been invoked to ensure there is no disruption to supply. As of today, all our manufacturing sites are operating under a Pfizer-wide pandemic preparedness plan.

In addition, we have identified several medicines used globally that are most relevant in today’s situation for hospitals and affected patients. We are developing specific risk plans for these medicines that include but are not limited to intensive monitoring of demand and shifting production plans to support higher demand and safety stocks.

We have implemented measures to protect our inventories and ensure supply continuity for the many essential medicines required by Canadian hospitals and patients. These measures include providing wholesalers with 1.5 times their normal inventory levels in order to bring more products closer to patients.

However, we are also implementing the use of ordering restrictions for products distributed to our direct and indirect customers. This firm but necessary approach has been taken to ensure our products remain available and continue to be distributed throughout the network as equitably as possible during this critical time.

We have also asked Canadian pharmacies to carefully manage the inventory they have available to patients, and to use their professional judgement when dispensing medication. It is critical that all medications and vaccines are being dispensed to patients in an equitable way.

We thank our customers and stakeholders for their continued understanding and cooperation.


For more information – Pfizer Canada Media Line: 1-866-9Pfizer (1-866-973-4937) or [email protected]